Novel risk assessment for the intensity of conditioning regimen in elderly patients

Author:

Akahoshi Yu1ORCID,Tada Yuma2,Sakaida Emiko3ORCID,Kusuda Machiko4,Doki Noriko5ORCID,Uchida Naoyuki6,Fukuda Takahiro7,Tanaka Masatsugu8,Sawa Masashi9,Katayama Yuta10ORCID,Matsuoka Ken-ichi11,Ozawa Yukiyasu12,Onizuka Makoto13,Kanda Junya14ORCID,Kanda Yoshinobu15,Atsuta Yoshiko16,Nakasone Hideki17ORCID

Affiliation:

1. Icahn School of Medicine at Mount Sinai, United States

2. Osaka International Cancer Institute, Osaka, Japan

3. Chiba University Hospital, Chiba, Japan

4. Saitama Medical Center, Jichi Medical University, Saitama city, Japan

5. Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

6. Toranomon Hospital, Tokyo, Japan

7. National Cancer Center Hospital, Tokyo, Japan

8. Kanagawa Cancer Center, Yokohama, Japan

9. Anjo Kosei Hospital, Anjo Aichi, Japan

10. Hiroshima Red-Cross Hospital, Hiroshima, Japan

11. Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

12. Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan, Nagoya, Japan

13. Tokai University School of Medicine, Isehara, Japan

14. Graduate School of Medicine, Kyoto University, Kyoto, Japan

15. Jichi Medical University, Japan

16. Aichi Medical University School of Medicine, Japan

17. Jichi Medical University Saitama Medical Center, Saitama-shi, Japan

Abstract

Reduced-intensity conditioning (RIC) regimens have long-term outcomes that are generally comparable to those with myeloablative conditioning (MAC) due to a lower risk of NRM but a higher risk of relapse. However, it is unclear how we should select the conditioning intensity in individual cases. We propose the Risk assessment for the Intensity of Conditioning regimen in Elderly patients (RICE) score. We retrospectively analyzed 6147 recipients aged 50-69 years using a Japanese registry database. Based on the interaction analyses, advanced age (≥ 60 y), Hematopoietic Cell Transplantation-Specific Comorbidity Index (≥ 2), and umbilical cord blood were used to design a scoring system to predict the difference in an individual patient's risk of nonrelapse mortality (NRM) between MAC and RIC - the RICE score, which is the sum of these three factors: 0 or 1, low RICE score; or 2 or 3, high RICE score. In multivariate analyses, RIC was significantly associated with a decreased risk of NRM in patients with a high RICE score (training cohort: HR, 0.73, 95%CI, 0.60-0.90, P = 0.003; validation cohort: HR, 0.57, 95%CI, 0.43-0.77, P < 0.001). In contrast, we found no significant differences in NRM between MAC and RIC in patients with a low RICE score (training cohort: HR, 0.99, 95%CI, 0.85-1.15, P = 0.860; validation cohort: HR, 0.81, 95%CI, 0.66-1.01, P = 0.061). In summary, a new and simple scoring system, the RICE score, appears to be useful for personalizing the conditioning intensity and might improve transplant outcomes in elderly patients.

Publisher

American Society of Hematology

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3